Posttraumatic Headache: Basic Mechanisms and Therapeutic Targets
被引:29
|
作者:
Kamins, Joshua
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, Los Angeles, CA 90095 USA
Univ Calif Los Angeles, David Geffen Sch Med, Tisch Brainsport Program, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, Los Angeles, CA 90095 USA
Kamins, Joshua
[1
,2
]
Charles, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, Los Angeles, CA 90095 USA
Charles, Andrew
[1
]
机构:
[1] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Tisch Brainsport Program, Los Angeles, CA 90095 USA
Frequent or continuous headache, often refractory to medical therapy, is a common occurrence after head trauma. In addition to being the most common acute symptom after traumatic brain injury (TBI), headache is also one of the most persistent and disabling symptoms. Different studies indicate that 18-58% of those suffering a TBI will have significant headache at 1 year following the trauma. In addition to being disabling on its own, posttraumatic headache (PTH) is a predictor of overall outcome after concussion. Despite its remarkable prevalence and associated social and economic costs, many fundamental and important questions about PTH remain unanswered. The purpose of this review is to identify key questions regarding the clinical characteristics of posttraumatic headache, its basic mechanisms, and its optimal management. We discuss phenotypic features of PTH, pathophysiological mechanisms of TBI including potential overlaps with those of migraine and other primary headache disorders, and potential novel targets for treatment. We suggest different strategies to finding answers to the questions regarding PTH in order to advance the understanding of the disorder and develop more effective therapies.
机构:
Ctr Retine Med, 187 Rue Menin, F-59520 Marquette Lez Lille, FranceCtr Retine Med, 187 Rue Menin, F-59520 Marquette Lez Lille, France
Desmettre, T.
Gatinel, D.
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Adolphe De Rothschild, Serv Ophtalmol, 25 Rue Manin, F-75940 Paris 19, FranceCtr Retine Med, 187 Rue Menin, F-59520 Marquette Lez Lille, France
Gatinel, D.
Leveziel, N.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Hosp Univ Poitiers, Serv Ophtalmol, 2 Rue Miletrie Cs 90577, F-86000 Poitiers, FranceCtr Retine Med, 187 Rue Menin, F-59520 Marquette Lez Lille, France
机构:
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Res Lab Tumor Epigenet & Genom,Canc Ctr, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Qiu, Lei
Jing, Qian
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Res Lab Tumor Epigenet & Genom,Canc Ctr, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Jing, Qian
Li, Yanbo
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Res Lab Tumor Epigenet & Genom,Canc Ctr, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Li, Yanbo
Han, Junhong
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Res Lab Tumor Epigenet & Genom,Canc Ctr, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Frontiers Sci Ctr Dis, State Key Lab Biotherapy, Chengdu 610041, Peoples R China